What is the fair value of ELAN stock?

Our analysis estimates the fair value range for ELAN to be between $22.26 and $23.04. The current price is $22.52.

What is the analyst price target for ELAN?

The average Wall Street analyst price target for ELAN is $30.31. This implies a potential upside of 34.6% from current levels.

Elanco Animal Health (ELAN) Stock: Buy, Sell, or Hold?

ELAN - Elanco Animal Health Incorporated Common Stock

PHARMACEUTICAL PREPARATIONS

$22.52

-0.17 (-0.75%) ▼

5d: -4.37%

30d: +0.76%

90d: -11.37%

WAIT

LOW Confidence

Protect Your ELAN Gains

Analysis Updated: Oct 23, 2026 12:00 AM ET

Earnings: Nov 06, 2026 12d

Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Oct 23, 2026 at $22.52 · last confirmed Oct 23, 2026

Strength: 4.5/10

Get Alerted When ELAN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
ℹ️ NEUTRAL: ELAN is fairly priced but lacks strong directional signals. At -4.9% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 13.1%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$39.27

Based on 8.6% avg growth

INTRINSIC VALUE TODAY

$24.38

7.6% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.3x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: ELAN is currently trading at $22.52, which is considered fair relative to its 30-day fair value range of $22.26 to $23.04. From a valuation perspective, the stock is trading at a discount (Forward PE: 17.5) compared to its historical average (20.3). Remarkably, the market is currently pricing in an annual earnings decline of 4.9% over the next few years. This pessimistic expectation contrasts with the company's recent 440.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, ELAN is in a downtrend. The price is currently testing key support at $22.03. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $30.31 (+34.6%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR

Historical Trading Range $22.26 - $23.04

Company Quality Score 47/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 72.4%

Protect Your Profits

Holding ELAN? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

NEUTRAL: Price in fair range
NEUTRAL: Mixed technical signals (47/100)
BULLISH: High volume confirmation
BULLISH: Trading 34.6% below Wall St target ($30.31)
WARNING: Composite score 47/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $22.26 - $23.04

Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $22.03

Resistance Level $24.11

Current Trend Downtrend

Technical data as of Oct 23, 2026

Fundamental Context

Forward P/E (Next Year Est.) 17.51

Wall Street Target $30.31 (+34.6%)

Revenue Growth (YoY) 10.2%

Earnings Growth (YoY) 440.5%

Profit Margin -4.0%

Valuation Discount vs History -4.9% cheaper

PE vs Historical 17.5 vs 20.3 CHEAP

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -4.9% (market-implied from PE analysis)

1-Year Target $21.42 (-5%)

2-Year Target $20.37 (-10%)

3-Year Target $19.37 (-14%)

3-Yr Target (if PE normalizes) (PE: 18→20) $22.46 (0%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 19.9, Growth: 13.1%) $37.01 (+64%)

Base: (SPY PE: 17.5, Growth: 13.1%) $32.62 (+45%)

Bear: (PE: 14.9, Growth: 13.1%) $27.73 (+23%)

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 17.5 to 20.3

Stabilization Target: $26.11 (+16.0%)

PE Expansion Potential: +16.0%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: October 23, 2026 8:08 PM ET
Data refreshes hourly during market hours. Next update: 9:08 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is ELAN showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

NEUTRAL

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for ELAN.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
NBIX Neurocrine Biosciences I…	STRONG BUY 29 analysts	$207	56 HOLD
AQST Aquestive Therapeutics I…	STRONG BUY 9 analysts	$9	65 BUY
ALKS Alkermes Plc	STRONG BUY 19 analysts	$56	38 SELL
AMLX Amylyx Pharmaceuticals I…	STRONG BUY 12 analysts	$43	54 HOLD
HROW Harrow Health Inc	STRONG BUY 9 analysts	$65	60 HOLD

NBIX Neurocrine Biosci…

56 HOLD

AQST Aquestive Therape…

65 BUY

ALKS Alkermes Plc

38 SELL

AMLX Amylyx Pharmaceut…

54 HOLD

HROW Harrow Health Inc

60 HOLD

Advanced ELAN Option Strategies

Professional options setups generated by AI based on today's ELAN price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ELAN

ELAN Technical Chart ELAN Price Prediction ELAN Earnings Date ELAN Investment Advisor ELAN Fair Price Analyzer ELAN Options Advisor ELAN Options Chain ELAN Options Analysis ELAN Competitors

Compare ELAN with Peers

ELAN vs AVTR
Which one to buy?

ELAN vs ZTS
Which one to buy?

ELAN vs BHC
Which one to buy?

ELAN vs BHVN
Which one to buy?

ELAN vs EHC
Which one to buy?

AMRX vs ELAN
Winner: ELAN

ALKS vs ELAN

AVTR vs ELAN
Winner: ELAN

ELAN vs LNTH
Winner: LNTH

UTHR vs ELAN

NBIX vs ELAN

Create New Comparison View All Competitors

Tradestie